A Drug Being Tested to Treat COVID-19 Is Almost Identical to a Black Market FIP Cure

Youve probably heard a lot about remdesevir in the news recently. Manufactured by Gilead Sciences, Inc., this drug has shown promise in helping patients infected with COVID-19. On May 1, the FDA issued an emergency authorization for potential COVID-19 treatment, and on Saturday, the Department of Health and Human Services said the states with the greatest number of COVID-19 cases have been allotted doses of the drug based on their case counts. Gilead has donated 1.5 million doses of the...